OR WAIT null SECS
June 28, 2021
Reports of myocarditis and pericarditis following Pfizer-BioNTech and Moderna vaccinations prompts warnings.
June 25, 2021
AbbVie has exercised its right to acquire TeneoOne, along with its lead immunotherapeutic asset for the potential treatment of multiple myeloma.
Amgen’s Aimovig has become the first and only approved treatment in Japan for treating migraine attacks in adults by blocking the CGRP-R.
FDA has granted breakthrough therapy designation to donanemab, Eli Lilly and Co.’s investigational antibody treatment for Alzheimer’s disease.
June 24, 2021
The companies will utilize the Cocoon Platform for clinical point-of-care manufacturing.
The companies have entered into an agreement to develop processes for a novel immunotherapy protein.
The University of Birmingham has been confirmed as the third National Training Centre in the Advanced Therapies Skills Training Network (ATSTN) initiative
June 23, 2021
GlaxoSmithKline will focus on vaccines and specialty medicines while spinning off consumer healthcare business.
The European Commission has purchased an additional 150 million doses of Moderna’s COVID-19 vaccine for delivery in 2022.
Centrient started production at its new statins API manufacturing unit in Toansa, India.